Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Insula Neuromodulation for Chronic Neuropathic Pain

NCT: NCT05404581 · RECRUITING

NCT IDNCT05404581
StatusRECRUITING
Start Date2022-11-01
Completion2028-07-01
SponsorUniversity of Virginia (OTHER)
First posted
Last updated

Brief Summary

This study will comprehensively investigate the insula as a brain target for neuromodulation to treat chronic neuropathic pain.

Frequently Asked Questions

What is Insula Neuromodulation for Chronic Neuropathic Pain?

Insula Neuromodulation for Chronic Neuropathic Pain is a clinical trial registered under NCT05404581. Current status: RECRUITING.

What is the status of NCT05404581?

The current status of NCT05404581 (Insula Neuromodulation for Chronic Neuropathic Pain) is: RECRUITING.

When did Insula Neuromodulation for Chronic Neuropathic Pain start?

Insula Neuromodulation for Chronic Neuropathic Pain started on 2022-11-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑